May 9, 2023 — AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) […] BOSTON–(BUSINESS WIRE)–Apr. 26, 2023– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved the […] SACRAMENTO, Calif. — Gov. Gavin Newsom declared last month that California was “done” doing business with Walgreens after the pharmacy […] ROP is a leading cause of childhood blindness worldwide Eylea now approved to treat five retinal conditions caused by ocular […] As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to […] Can’t see the audio player? Click here to listen on SoundCloud. You can also listen on Spotify, Apple Podcasts, Stitcher, […] Desperation led José Luis Hernández to ride atop a speeding train through northern Mexico with hopes of reaching the United […] DUBLIN, Aug. 12, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration […] TITUSVILLE, N.J. – July 30, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. […] Can’t see the audio player? Click here to listen on SoundCloud. You can also listen on Spotify, Apple Podcasts, Stitcher, […]Medications
Farxiga Extended in the US to Reduce Risk of Cardiovascular Death and Hospitalisation for Heart Failure to a Broader Range of Patients
Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 2 Through 5 With Certain Mutations
Gov. Newsom Wanted California to Cut Ties With Walgreens. Then Federal Law Got in the Way.
Eylea (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments
KHN’s ‘What the Health?’: The Autumn of Democrats’ Discontent
No Papers, No Care: Disabled Migrants Seek Help Through Lawsuit, Activism
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults
Uptravi (selexipag) Receives FDA Approval for Intravenous Use in Adult Patients with Pulmonary Arterial Hypertension (PAH)
KHN’s ‘What the Health?’: Hot Covid Summer
Copyright © 2023